Debiopharm Innovation Fund
Debiopharm Innovation Fund is a company founded in 2008.
All edits
Debiopharm Innovation Fund - also known as Debiopharm Diagnostics - is the venture capital subsidiary of Debiopharm Group. The firm has been in operations since 2008. It specializes in funding companies that are developing smart data and digital health products and services dedicated intended for drug development and patient journey in the field of oncology and infectious diseases. Debiopharm Innovation Fund prefers to fund companies during the Series A and B financing round. As of January 2020, Debiopharm Innovation Fund has invested in 19 companies and has sold off its stakes in eight of them.
Debiopharm Innovation Fund
Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.
Debiopharm Innovation Fund - also known as Debiopharm Diagnostics - is the venture capital subsidiary of Debiopharm Group. The firm has been in operations since 2008. It specializes in funding companies that are developing smart data and digital health products and services dedicated intended for drug development and patient journey in the field of oncology and infectious diseases. Debiopharm Innovation Fund prefers to fund companies during the Series A and B financing round. As of January 2020, Debiopharm Innovation Fund has invested in 19 companies and has sold off its stakes in eight of them.
Debiopharm Innovation Fund
Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.
Find more companies like Debiopharm Innovation Fund
